drugset / Trial / NCT02608242
PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin
RandomizedCrossoverOpen-labelTreatment
Summary
This is a Randomized, open-label, single-dose, 3-treatment, 3-period, 3-sequence crossover design.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | Oral |
| Comparator | Rosuvastatin | Small molecule | 20 mg | Oral |
| Comparator | Telmisartan | Other / unclassified | 80 mg | Oral |
| Subject | YH22189 | Unknown | — | Oral |